Sun Pharma surges with its arm getting preliminary injunctive relief Prohibiting Biofrontera

27 Dec 2018 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 420.70, up by 6.70 points or 1.62% from its previous closing of Rs. 414.00 on the BSE.

The scrip opened at Rs. 423.25 and has touched a high and low of Rs. 424.00 and Rs. 419.50 respectively. So far 52329 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 391.10 on 11-Dec-2018.

Last one week high and low of the scrip stood at Rs. 434.40 and Rs. 410.30 respectively. The current market cap of the company is Rs. 99332.19 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 33.31% and 12.31% respectively.

Sun Pharmaceutical Industries’ wholly owned subsidiary -- DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG from using DUSA's confidential and proprietary trade secret information.

Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1777.65 2.45 (0.14%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.